Table 1.
Average optical density of p53, Bcl-2 and Bax in different groups 48 h after treatment (mean ± SD)
| Group | n | p53 | Bcl-2 | Bax |
| A | 6 | 0.208 ± 0.009 | 0.086 ± 0.010 | 0.091 ± 0.0013 |
| B | 6 | 0.223 ± 0.0133 | 0.056 ± 0.0064 | 0.135 ± 0.0095 |
| C | 6 | 0.255 ± 0.0111 | 0.064 ± 0.0048 | 0.128 ± 0.0144 |
| D | 6 | 0.197 ± 0.0157 | 0.058 ± 0.0095 | 0.151 ± 0.011 |
| E | 6 | 0.205 ± 0.100 | 0.054 ± 0.0090 | 0.150 ± 0.028 |
| F | 6 | 0.155 ± 0.0115 | 0.026 ± 0.0170 | 0.207 ± 0.027 |
| F | 40.810b | 21.466b | 23.912b |
Group A: hyperthermia; group B: chemotherapy; group C: themo-chermotherapy; group D: radiation; group E: themoradiotherapy; group F: thempchempradiotherapy.
b
P < 0.01 in groups A-F. Comparison of average optical density of Bcl-2, Bax and p53 genes in different groups was made by mono-factor variance analysis. SNQ test was used to compare the two groups.